Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
HER2 Positive Early Breast Cancer
Munich, Bavaria
HER2 Positive Early Breast Cancer Clinical Trials in Munich, Bavaria
1 recruiting
Munich, Bavaria, Germany
Showing
1–1
of
1
trials
Recruiting
Phase 2
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
HER2 Positive Early Breast Cancer
West German Study Group
702 enrolled
44 locations
NCT05704829
Feedback